Back to search

Sweden· SE-20111119000042

Viread 204 mg Filmdragerad tablett

A medicinal product containing tenofovir disoproxil, registered in Sweden by Gilead Sciences Ireland UC.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedViread 204 mg Filmdragerad tablettATC—REGISTER NO.SE-20111119000042PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Tenofovir Disoproxil
Manufacturer
Gilead Sciences Ireland UC
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20111119000042

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Tenofovir disoproxil in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenofovir disoproxil products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

  • Austria · Tenofovir Disoproxil Accordpharma, Tenofovir Ratiopharm
  • Bulgaria · Тенофовир Зентива, Тенофовир Полфарма
  • Cyprus · Tenoviral
  • Czechia · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Sandoz
  • Germany · Tenofovirdisoproxil Accord, Tenofovirdisoproxil Al
  • Denmark · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Glenmark
  • Estonia · Tenofovir Disoproxil Sandoz
  • Spain · Tenofovir Disoproxilo Accordpharma, Tenofovir Disoproxilo Aurovitas
  • Finland · Tenofovir Disoproxil Hexal, Tenofovir Disoproxil Sandoz
  • France · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Arrow
  • United Kingdom (Northern Ireland) · Tenofovir Disoproxil, Tenofovir Disoproxil Accordpharma
  • Greece · Agardon, Tenofovir Disoproxil Accord Pharma
  • Croatia · Teynofor
  • Hungary · Tenofovir Disoproxil Accordpharma, Tenofovir Onkogen
  • Ireland · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Teva
  • Iceland · Tenofovir Disoproxil Viatris, Tenofovir Disoproxil Zentiva
  • Italy · Tenofovir Disoproxil Aurobindo, Tenofovir Disoproxil Doc Generici
  • Liechtenstein · Tenofovir Disoproxil Viatris, Tenofovir Disoproxil Zentiva
  • Latvia · Tenofovir Disoproxil Teva
  • Netherlands · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Accordpharma
  • Norway · Filmdrasjerte Tabletter Viatris, Tenofovir Disoproxil Accordpharma
  • Poland · Tenofovir Disoproxil Accordpharma, Tenofovir Disoproxil Aurovitas
  • Portugal · Tenofovir Accord, Tenofovir Aurobindo
  • Romania · Tenofovir Disoproxil Accord, Tenofovir Disoproxil Accordpharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f184e8ce-f50b-43d2-a68d-4c8542a2abe0
GET /v1/drugs/f184e8ce-f50b-43d2-a68d-4c8542a2abe0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "EPAR",
    "EMA"
  ],
  "se_npl_id": "20111119000042",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20111119000042",
  "product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/viread-epar-product-information_sv.pdf"
}

See everything about tenofovir disoproxil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.